An ovarian cancer blog which includes quality resource materials: education, research, social networking, genetics and (some) healthcare politics.
“Not everything that can be counted counts and not everything that counts can be counted.”
Albert Einstein
|
|
|
|
|
|
|
|
|
|
Furthermore, our findings provide evidence that proficiency in NER or MMR may account for mechanisms of PARPi resistance, other than mutation reversal or p-glycoprotein up-regulation [55], to explain why BRCA mutated EOC patients do not respond favorably to Olaparib.
0 comments :
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.